# Octapharma Plasma Inc – FDA Inspection, Apr 12, 2013

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5c17b9fe-0ce2-4c24-93d7-3432101ad0e3
Source feed: FDA_Inspections

> FDA inspection 827645 of Octapharma Plasma Inc, April 12, 2013. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 827645
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2013-04-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1252471 - 2025-01-16
- FDA Inspection 1017592 - 2017-06-09
- FDA Inspection 937941 - 2015-08-05
- [FDA Inspection 685909 - 2010-09-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0b328cda-9d43-40b9-91c4-0a8caadff993)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8d50af8d-62b1-493c-a055-124a81193e8b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d